BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 2751741)

  • 1. Effect of an aluminium-hydroxide containing antacid on the oral bioavailability of pirenzepine.
    Vergin H; Herrlinger C; Gugler R
    Arzneimittelforschung; 1989 Apr; 39(4):520-3. PubMed ID: 2751741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of an aluminum- and magnesium-containing antacid on the bioavailability of garenoxacin in healthy volunteers.
    Krishna G; Kisicki JC; Olsen S; Grasela DM; Wang Z
    Pharmacotherapy; 2007 Jul; 27(7):963-9. PubMed ID: 17594201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of concomitantly administered antacids on the bioavailability of lornoxicam, a novel highly potent NSAID.
    Dittrich P; Radhofer-Welte S; Magometschnigg D; Kukovetz WR; Mayerhofer S; Ferber HP
    Drugs Exp Clin Res; 1990; 16(2):57-62. PubMed ID: 2401187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced oral itraconazole bioavailability by antacid suspension.
    Lohitnavy M; Lohitnavy O; Thangkeattiyanon O; Srichai W
    J Clin Pharm Ther; 2005 Jun; 30(3):201-6. PubMed ID: 15896236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clopidogrel bioavailability: absence of influence of food or antacids.
    McEwen J; Strauch G; Perles P; Pritchard G; Moreland TE; Necciari J; Dickinson JP
    Semin Thromb Hemost; 1999; 25 Suppl 2():47-50. PubMed ID: 10440423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics and bioequivalence of different formulations of pirenzepine.
    Vergin H; Mascher H; Strobel K; Nitsche V
    Arzneimittelforschung; 1986 Sep; 36(9):1409-12. PubMed ID: 3790194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of pharmacokinetic interaction between linezolid and antacid in healthy volunteers.
    Grunder G; Zysset-Aschmann Y; Vollenweider F; Maier T; Krähenbühl S; Drewe J
    Antimicrob Agents Chemother; 2006 Jan; 50(1):68-72. PubMed ID: 16377669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of food and antacids on the pharmacokinetics of eltrombopag in healthy adult subjects: two single-dose, open-label, randomized-sequence, crossover studies.
    Williams DD; Peng B; Bailey CK; Wire MB; Deng Y; Park JW; Collins DA; Kapsi SG; Jenkins JM
    Clin Ther; 2009 Apr; 31(4):764-76. PubMed ID: 19446149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of antacid and ranitidine on droxicam pharmacokinetics.
    Bartlett A; Costa A; Martínez L; Roser R; Sagarra R; Sánchez J
    J Clin Pharmacol; 1992 Dec; 32(12):1115-9. PubMed ID: 1487550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigation of the possible influence of the absorption of vinpocetine with concomitant application of magnesium-aluminium-hydroxide gel.
    Lohmann A; Grobara P; Dingler E
    Arzneimittelforschung; 1991 Nov; 41(11):1164-7. PubMed ID: 1810262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of acarbose and simultaneous antacid therapy on blood glucose.
    Höpfner M; Durani B; Spengler M; Fölsch UR
    Arzneimittelforschung; 1997 Oct; 47(10):1108-11. PubMed ID: 9368703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of aluminium hydroxide on the bioavailability of feprazone. Single dose study.
    Spahn H; Mutschler E
    Arzneimittelforschung; 1985; 35(1):167-9. PubMed ID: 4039147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the influence of antacids and H2 antagonists on the absorption of moxifloxacin after oral administration of a 400mg dose to healthy volunteers.
    Stass H; Böttcher MF; Ochmann K
    Clin Pharmacokinet; 2001; 40 Suppl 1():39-48. PubMed ID: 11352441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of antacid suspension on the pharmacokinetics of ibuprofen.
    Gontarz N; Small RE; Comstock TJ; Stalker DJ; Johnson SM; Willis HE
    Clin Pharm; 1987 May; 6(5):413-6. PubMed ID: 3665393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Rennie Liquid versus Maalox Liquid on intragastric pH in a double-blind, randomized, placebo-controlled, triple cross-over study in healthy volunteers.
    Hürlimann S; Michel K; Inauen W; Halter F
    Am J Gastroenterol; 1996 Jun; 91(6):1173-80. PubMed ID: 8651166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of effect of omeprazole or of an aluminium hydroxide/magnesium hydroxide antacid on the pharmacokinetics of lumiracoxib.
    Scott G; Vinluan Reynolds C; Milosavljev S; Langholff W; Shenouda M; Rordorf C
    Clin Pharmacokinet; 2004; 43(5):341-8. PubMed ID: 15080766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiotelemetric comparison of two antacids using the Heidelberg capsule.
    Gómez Puch LM; Ríos Solans G; Muñoz y Fernandez JR
    Arzneimittelforschung; 1984; 34(10A):1378-80. PubMed ID: 6548925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antacid activity of calcium carbonate and hydrotalcite tablets. Comparison between in vitro evaluation using the "artificial stomach-duodenum" model and in vivo pH-metry in healthy volunteers.
    Vatier J; Ramdani A; Vitré MT; Mignon M
    Arzneimittelforschung; 1994 Apr; 44(4):514-8. PubMed ID: 8011006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Absence of in vivo and in vitro interactions of an aluminum hydroxide, magnesium hydroxide containing antacid with cimetidine in patients with peptic ulcer.
    Allgayer H; Röllinghoff W; Paumgartner G
    Z Gastroenterol; 1983 Jul; 21(7):351-4. PubMed ID: 6613216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of two antacid preparations on intragastric acidity--a two-centre open randomised cross-over placebo-controlled trial.
    Sulz MC; Manz M; Grob P; Meier R; Drewe J; Beglinger C
    Digestion; 2007; 75(2-3):69-73. PubMed ID: 17496418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.